Citadel Advisors
MKUL

Citadel Advisors’s Molekule Group, Inc. Common Stock MKUL Stock Holding History

Citadel Advisors’s Portfolio MKUL Stock Details MKUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-39,512
Closed -$518K – 13960
2022
Q2 		$518K Buy
+39,512
New +$233K ﹤0.01% 8569

Other funds holding MKUL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors's MKUL Position: Q3 2022 in Review

Citadel Advisors sold out of Molekule Group, Inc. Common Stock (MKUL) in Q3 2022, closing a stake of 39,512 shares — an estimated $518K sold.

Citadel Advisors first reported a position in MKUL in Q2 2022 and held it in 1 quarter. The position peaked at $518K in Q2 2022. 17 funds tracked by Wall St. Rank hold MKUL as of Q3 2022.

  • Citadel Advisors reported no remaining Molekule Group, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 39,512 Molekule Group, Inc. Common Stock shares in Q3 2022, an estimated $518K.
  • Citadel Advisors first reported a position in Molekule Group, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Citadel Advisors's Molekule Group, Inc. Common Stock position peaked at $518K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Molekule Group, Inc. Common Stock as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.